EPCs are regarded as the potential strategy for the repairing ischemic brain injury. However, researchers realize their undesirable treatment efficiency due to low survival rate of the transplanted stem cells. Therefore, it is of the most urgency to improve the EPCs survival and physiological function under hypoxia condition in the ischemic brain tissue. Our previous study showes that microRNA-210, a key hypoxia associated miRNA, possesses strong anti-apoptosis , and promotes angiogenesis and neurogenesis properties. However, EPCs overexpressing miRNA-210 improves the transplanted EPCs survival and physiological function is unknown. In present study, we use lentiviral vector to transduce miR-210 gene into EPCs to improve the EPCs survival. In the presence of increased miR-210 level in the ischemic region, both angiogenesis and neurogenesis are noticeably improved.The hypotheses include: 1) Compared to the EPC alone, if LV-miR-210-EPC have better action in decreasing infarct volume and improving long-term outcomes in mice with middle cerebral artery occlusion? 2) If EPCs overexpressing miRNA-210 improves the transplanted EPCs survival and physiological function? 3) If miR-210 playes a partial role in the direct signal regulation via NDUFA4,VEGF or BDNF? Our study is of great values in promoting a better understanding of post-ischemic injury repairing and pathophysiology, ultimately providing a potential novel therapeutic target for stroke.
内皮祖细胞(EPCs)移植是治疗脑缺血热点策略,但移植细胞生存率低影响疗效,提高EPCs在缺血脑组织中的生存能力并发挥其生理功能是亟待解决的问题。我们前期研究发现缺血区microRNA-210(miR-210)增高具有强大的调节细胞抗缺氧凋亡及促血管神经再生作用。本课题拟利用慢病毒介导miR-210修饰EPCs(LV-miR-210-EPCs)这一新方法以达到增强EPCs生存能力和生理功能的目的,探索 1)与单纯EPC治疗相比,LV-miR-210-EPCs是否具有更有效的减小脑缺血小鼠梗死面积并改善其神经行为学的治疗作用;2)miR-210过表达是否能增加移植的EPC存活并促进其生理功能发挥;3)miR-210是否直接调控下游靶点NDUFA4、VEGF和BDNF而发挥抗缺血缺氧、抗细胞凋亡和促血管新生/神经再生作用。本研究有助进一步阐明脑缺血损伤发病机制,为缺血性卒中提供潜在治疗新靶点。
内皮祖细胞(EPCs)移植是治疗脑缺血热点策略,但移植治疗效率很大程度上取决于脑缺血区EPC的数量及功能,脑缺血区域的低氧环境不利于EPC的存活,提高EPCs在缺血脑组织中的生存能力并发挥其生理功能是亟待解决的问题。我们前期研究发现缺血区microRNA-210(miR-210)增高具有强大的调节细胞抗缺氧凋亡及促血管神经再生作用,本课题主要是利用慢病毒介导miR-210修饰EPCs(LV-miR-210-EPCs)这一新方法以达到增强EPCs生存能力和生理功能的目的。本研究首先在体外采用OGD模型处理EPC模拟缺血环境,发现过表达miR-210-3p能提高EPC抗缺氧能力以及其在OGD环境中的促血管新生能力,表现为存活、增殖、移行以及成管能力均增强,而抑制miR-210-3p则减弱OGD处理的EPC的上述功能;进一步在体实验发现miR-210-3p转染的EPC较未处理的EPC有更强的在脑缺血小鼠脑中存活及促血管新生的能力,减小脑梗死体积并改善其神经功能缺损;进一步分子机制研究以及基因荧光报告系统证实miR-210-3p在转录后水平调控直接靶点VEGF, BDNF以及RGMA蛋白表达,从而改善EPC的抗缺血缺氧及促血管新生的能力。本研究有助进一步阐明脑缺血损伤发病机制,为缺血性卒中提供潜在治疗新靶点,也为干细胞治疗提供了新的手段。
{{i.achievement_title}}
数据更新时间:2023-05-31
Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression
Complete loss of RNA editing from the plastid genome and most highly expressed mitochondrial genes of Welwitschia mirabilis
湖北某地新生儿神经管畸形的病例对照研究
青藏高原--现代生物多样性形成的演化枢纽
骨髓间充质干细胞源外泌体调控心肌微血管内皮细胞增殖的机制研究
激活AMPK调节内皮祖细胞治疗长爪沙鼠全脑缺血的作用及机制研究
慢病毒介导ChABC基因修饰神经干细胞治疗脊髓损伤的研究
移植慢病毒介导hVEGF165-EGFP双表达基因转染的内皮祖细胞防治多器官功能障碍研究
茶多酚介导糖尿病内皮祖细胞修复内皮损伤的作用及机制研究